Doximity, Inc. (NYSE:DOCS) Given Average Rating of “Buy” by Analysts

Doximity, Inc. (NYSE:DOCS) has been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company.

A number of analysts have weighed in on DOCS shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Doximity in a report on Wednesday, December 24th. Royal Bank Of Canada upgraded shares of Doximity to a “moderate buy” rating in a research note on Thursday, January 8th. Barclays raised shares of Doximity to a “strong-buy” rating in a report on Monday, December 8th. Wall Street Zen cut Doximity from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Finally, Truist Financial upgraded Doximity from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 8th.

Doximity Trading Up 0.6%

DOCS stock opened at $41.28 on Friday. Doximity has a 12-month low of $39.95 and a 12-month high of $85.21. The company has a market cap of $7.77 billion, a P/E ratio of 32.76, a PEG ratio of 1.90 and a beta of 1.39.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.